机器人乳房切除与开放手术随机对照试验
这项III期单中心随机对照试验纳入80例乳腺癌或BRCA突变女性,比较机器人辅助与开放保留乳头乳房切除术。结果显示机器人手术时间延长1小时18分钟,并发症无差异,但机器人组乳房满意度及心理社会、身体、性健康评分显著更高,身体意象评分更优。中位随访28.6个月无局部事件。
要点
- 机器人保留乳头乳房切除术安全,并发症与开放手术无差异。
- 机器人组生活质量维持,开放组身体和性健康显著下降。
- 机器人手术时间较开放手术延长1小时18分钟。
核心结论
- 机器人保留乳头乳房切除术并发症与开放手术相似,安全性得到支持。
- 机器人手术后生活质量得以维持,而开放手术后显著下降。
- 早期随访未观察到局部失败。
研究设计与样本
- III期、开放标签、单中心随机对照试验,纳入80例乳腺癌(69例)或BRCA突变(11例)女性。
- 主要结局为手术并发症和生活质量(使用经验证问卷),次要结局包括肿瘤学结局。
主要发现
- 机器人手术时间比开放手术长1小时18分钟(P < 0.001)。
- 并发症数量或类型无差异(P = 0.11)。
- 机器人组Breast-Q乳房满意度、心理社会、身体和性健康评分显著高于开放组。
- 相对于基线,机器人组身体和性健康领域保持稳定,而开放组显著下降(P < 0.02)。
- 身体意象量表总分机器人组为20.7 ± 13.8,开放组为9.9 ± 5.1,P < 0.0001。
关键数值与推荐
- 中位随访28.6个月(范围3.7-43.3),未观察到局部事件。
- 机器人手术时间较开放手术延长1小时18分钟(P < 0.001)。
- 并发症无差异(P = 0.11)。
- 身体意象量表评分机器人组20.7 ± 13.8 vs 开放组9.9 ± 5.1(P < 0.0001)。
临床怎么用
- 机器人保留乳头乳房切除术可作为乳腺癌或BRCA突变女性的一种安全选择,并发症与开放手术相当。
- 对于注重术后生活质量和身体意象的患者,机器人手术可能更具优势。
- 需考虑机器人手术时间较长,可能影响手术安排。
局限性
- 单中心研究,样本量80例,随访时间中位28.6个月,早期结果需更长期验证。
- 开放标签设计可能影响生活质量主观评价。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim of this study was to compare robotic mastectomy with open classical technique outcomes in breast cancer patients. SUMMARY BACKGROUND DATA: As the use of robotic nipple sparing mastectomy continues to rise, improved understanding of the surgical, oncologic, and quality of life outcomes is imperative for appropriate patient selection as well as to better understand indications, limits, advantages, and dangers. METHODS: In a phase III, open label, single-center, randomized controlled trial involving 80 women with breast cancer (69) or with BRCA mutation (11), we compared the outcome of robotic and open nipple sparing mastectomy. Primary outcomes were surgical complications and quality of life using specific validated questionnaires. Secondary objective included oncologic outcomes. RESULTS: Robotic procedure was 1 hour and 18 minutes longer than open (P < 0.001). No differences in the number or type of complications (P = 0.11) were observed. Breast-Q scores in satisfaction with breasts, psychosocial, physical and sexual well-being were significantly higher after robotic mastectomy versus open procedure. Respect to baseline, physical and sexual well-being domains remained stable after robotic mastectomy, whereas they significantly decreased after open procedure (P < 0.02). The overall Body Image Scale questionnaire score was 20.7 ± 13.8 versus 9.9 ± 5.1 in the robotic versus open groups respectively, P < 0.0001. At median follow-up 28.6months (range 3.7-43.3), no local events were observed. CONCLUSIONS: Complications were similar among groups upholding the robotic technique to be safe. Quality of life was maintained after robotic mastectomy while significantly decrease after open surgery. Early follow-up confirm no premature local failure.ClinicalTrials.gov NCT03440398.
引用
- Toesca A, Sangalli C, Maisonneuve P, et al. A Randomized Trial of Robotic Mastectomy Versus Open Surgery in Women With Breast Cancer or BrCA Mutation. Ann Surg. 2021. PMID: 34597010. doi:10.1097/SLA.0000000000004969
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。